Immunogenicity of trivalent influenza vaccine in patients with lung cancer undergoing anticancer chemotherapy

• Main Authors: Kei Nakashima (Author), Masahiro Aoshima (Author), Satoko Ohfuji (Author), Kanzo Suzuki (Author), Masahiro Katsurada (Author), Naoko Katsurada (Author), Masafumi Misawa (Author), Yoshihito Otsuka (Author), Kyoko Kondo (Author), Yoshio Hirota (Author)
• Format: Book
• Published: Taylor & Francis Group, 2017-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Lung cancer is a leading cause of cancer-related death, and patients with lung cancer are a priority group for influenza vaccination. However, few studies have assessed the immunogenicity of the influenza vaccine in these patients. Here, we performed a prospective study to evaluate the immunogenicit...